Found 13 matching trials
Administration of Virus-Specific Cytotoxic T-Lymphocytes
PHASE1The main purpose of this study is to see if these T-lymphocytes are safe. T...
Location
National Institute of Health (NIH)
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
PHASE1This phase I trial studies the side effects of allogeneic adenovirus-specif...
Location
M D Anderson Cancer Center
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_PHASE1This trial studies the side effects and how well allogeneic cytomegalovirus...
Location
Nationwide Children's Hospital
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV
PHASE1This protocol is a phase I study. Patients may be eligible for an infusion ...
Location
Medical College of Wisconsin
Allogeneic Virus-specific T Cell Lines (VSTs)
PHASE1The primary purpose of the study is to evaluate whether most closely HLA-ma...
Location
Childrens National Medical Center
Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
PHASE1This trial is designed to evaluate the feasibility, safety and efficacy of ...
Location
Children's Hospital of Los Angeles
Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
NAPatients enrolled on this study will have received a stem cell transplant. ...
Location
Houston Methodist Hospital
ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus
PHASE1The subjects eligible for this trial have a type of blood cell cancer, othe...
Location
Houston Methodist Hospital
Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
N/ASubjects have a type of blood cell cancer, other blood disease or a genetic...
Status
No Longer Available
Location
Houston Methodist Hospital
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
PHASE1Patient's on this protocol have a type of blood cell cancer, other blood di...
Location
Houston Methodist Hospital